- Prevention / Eye Care
- Treatment
Antibiotic eye drops are used to treat or prevent the infection of eye and eye related infections. Many types bacteria causes the eye infections and most commonly caused eye infection is conjunctivitis. Different types of eye drops are used to treat the different types of eye infections. Broad spectrum antibiotics are primary choice for the bacterial eye infections and may be given in combinations or individually.
Global Antibiotic Eye Drops Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
x%
Largest Market
North-America
Fastest Growing Market
Europe
Antibiotic Eye Drops Market Dynamics
Factors such as increase in prevalence of the eye related infections such as conjunctivitis and rise in geriatric population globally expected drive the market growth over the forecast period. In addition, increase in R&D to develop the new antibiotic eye drops, rise in awareness about the infection among the people and advancements in the diagnostic techniques projected to bolster the market growth in near future. Moreover, increase in antibiotic resistance ocular infections creating the demand for new antibiotic eye drop products in the market. However, high cost of product development and maintenance of aseptic conditions for eye drops are expected to hamper the market growth over the forecast period.
North-America got Significant Share
Antibiotic Eye Drops Market Regional Analysis
Geographically, global antibiotic eye drops Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America antibiotic eye drops market projected to have the significant growth rate owing to the high incidence rates of bacterial conjunctivitis in the region. According to a recent survey published in the JAMA (Journal of the American Medical Association) over 50% of the conjunctivitis in U.S. are bacterial origin. Furthermore, presence of the key market players, recent product launches expected to boost the regional market growth over the forecast period. Europe bacterial conjunctivitis market expected to grow at notable rates owing to the presence increase in incidence of bacterial eye infections and rise in awareness. Furthermore, market players are adopting strategies such as collaborations and acquisitions to expand the market position.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Antibiotic Eye Drops Market Segmentation
By Purpose
By Antibiotic Type
- Bactericidal Drops
- Bacteriostatic Drops
- Combination Drops
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Frequently Asked Questions
North America holds highest share in 2022.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Antibiotic Eye Drops Market Introduction |
| 2.1.Global Antibiotic Eye Drops Market - Taxonomy |
| 2.2.Global Antibiotic Eye Drops Market - Definitions |
| 2.2.1.Dosage |
| 2.2.2.Route of Administration |
| 2.2.3.Distribution Channel |
| 2.2.4.Region |
| 3.Global Antibiotic Eye Drops Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Antibiotic Eye Drops Market Analysis, 2018-2022 and Forecast 2023-2029 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Antibiotic Eye Drops Market By Dosage, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 5.1. Eye Drops |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Gels & Creams |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Tablets and Capsules |
| 5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Antibiotic Eye Drops Market By Route of Administration, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 6.1. Antibiotics |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Fluoroquinalones |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Aminoglycosides |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Macrolides |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Antibiotic Eye Drops Market By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 7.1. Hospital Pharmacies |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Retail Pharmacies |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Online Pharmacies |
| 7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Antibiotic Eye Drops Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Antibiotic Eye Drops Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 9.1. Dosage Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Eye Drops |
| 9.1.2.Gels & Creams |
| 9.1.3.Tablets and Capsules |
| 9.1.4.Others |
| 9.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Antibiotics |
| 9.2.2.Fluoroquinalones |
| 9.2.3.Aminoglycosides |
| 9.2.4.Macrolides |
| 9.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospital Pharmacies |
| 9.3.2.Retail Pharmacies |
| 9.3.3.Online Pharmacies |
| 9.3.4.Others |
| 9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Antibiotic Eye Drops Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 10.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Eye Drops |
| 10.1.2.Gels & Creams |
| 10.1.3.Tablets and Capsules |
| 10.1.4.Others |
| 10.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Antibiotics |
| 10.2.2.Fluoroquinalones |
| 10.2.3.Aminoglycosides |
| 10.2.4.Macrolides |
| 10.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospital Pharmacies |
| 10.3.2.Retail Pharmacies |
| 10.3.3.Online Pharmacies |
| 10.3.4.Others |
| 10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Antibiotic Eye Drops Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 11.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Eye Drops |
| 11.1.2.Gels & Creams |
| 11.1.3.Tablets and Capsules |
| 11.1.4.Others |
| 11.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Antibiotics |
| 11.2.2.Fluoroquinalones |
| 11.2.3.Aminoglycosides |
| 11.2.4.Macrolides |
| 11.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospital Pharmacies |
| 11.3.2.Retail Pharmacies |
| 11.3.3.Online Pharmacies |
| 11.3.4.Others |
| 11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Antibiotic Eye Drops Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 12.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Eye Drops |
| 12.1.2.Gels & Creams |
| 12.1.3.Tablets and Capsules |
| 12.1.4.Others |
| 12.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Antibiotics |
| 12.2.2.Fluoroquinalones |
| 12.2.3.Aminoglycosides |
| 12.2.4.Macrolides |
| 12.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospital Pharmacies |
| 12.3.2.Retail Pharmacies |
| 12.3.3.Online Pharmacies |
| 12.3.4.Others |
| 12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Antibiotic Eye Drops Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
| 13.1. Dosage Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Eye Drops |
| 13.1.2.Gels & Creams |
| 13.1.3.Tablets and Capsules |
| 13.1.4.Others |
| 13.2. Route of Administration Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Antibiotics |
| 13.2.2.Fluoroquinalones |
| 13.2.3.Aminoglycosides |
| 13.2.4.Macrolides |
| 13.3. Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospital Pharmacies |
| 13.3.2.Retail Pharmacies |
| 13.3.3.Online Pharmacies |
| 13.3.4.Others |
| 13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Bausch + Lomb (U.S.) |
| 14.2.2.Abbott Laboratories (U.S.) |
| 14.2.3.Alcon (U.S.) |
| 14.2.4.Allergan plc (Ireland) |
| 14.2.5.Rohto Pharmaceutical Co., Ltd. (Japan) |
| 14.2.6.Similasan AG (Switzerladn) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Bausch + Lomb (U.S.)
- Abbott Laboratories (U.S.)
- Alcon (U.S.)
- Allergan plc (Ireland)
- Rohto Pharmaceutical Co., Ltd. (Japan)
- Similasan AG (Switzerladn)